Tetrahydroisoquinoline-Triazole Derivatives: Novel Nicotinamide <i>N</i>-Methyltransferase Inhibitors
Through the Lilly Open Innovation Drug Discovery program (OIDD), we discovered five cationic bis(aryltriazol-4-yl)methyl)-6,7-dimethoxytetrahydroisoquinolinium derivatives that effectively inhibit human nicotinamide N-methyltransferase. Compounds <b>4a</b>, <b>4c</b>, and <...
Main Authors: | Alison T. Ung, Matthew Payne |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | AppliedChem |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-9623/3/4/32 |
Similar Items
-
Rethinking the bioavailability and cellular transport properties of S-adenosylmethionine
by: Yudong Sun, et al.
Published: (2021-12-01) -
NNMT‐DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition
by: Changqing Wu, et al.
Published: (2023-01-01) -
Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy
by: Xiao-Yu Li, et al.
Published: (2022-06-01) -
Nicotinamide N-Methyltransferase Suppression Participates in Nickel-Induced Histone H3 Lysine9 Dimethylation in BEAS-2B Cells
by: Qian Li, et al.
Published: (2017-04-01) -
The association between nicotinamide N-methyltransferase gene polymorphisms and primary hypertension in Chinese Han Population
by: Xiang-Xiang Guan, et al.
Published: (2021-03-01)